Annual Revenue
$31.91 M
+$846.00 K+2.72%
01 July 2024
Summary:
Enzo Biochem annual revenue is currently $31.91 million, with the most recent change of +$846.00 thousand (+2.72%) on 01 July 2024. During the last 3 years, it has fallen by -$85.82 million (-72.90%). ENZ annual revenue is now -72.90% below its all-time high of $117.73 million, reached on 31 July 2021.ENZ Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$7.53 M
-$496.00 K-6.18%
01 July 2024
Summary:
Enzo Biochem quarterly revenue is currently $7.53 million, with the most recent change of -$496.00 thousand (-6.18%) on 01 July 2024. Over the past year, it has dropped by -$280.00 thousand (-3.59%). ENZ quarterly revenue is now -77.89% below its all-time high of $34.05 million, reached on 31 January 2022.ENZ Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$31.91 M
-$1.43 M-4.30%
01 July 2024
Summary:
Enzo Biochem TTM revenue is currently $31.91 million, with the most recent change of -$1.43 million (-4.30%) on 01 July 2024. Over the past year, it has increased by +$143.00 thousand (+0.45%). ENZ TTM revenue is now -73.00% below its all-time high of $118.17 million, reached on 31 January 2022.ENZ TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.7% | -3.6% | +0.5% |
| 3 y3 years | -72.9% | -71.6% | -72.4% |
| 5 y5 years | -60.7% | -62.8% | -60.2% |
ENZ Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -72.9% | +2.7% | -77.9% | +113.9% | -73.0% | +199.6% |
| 5 y | 5 years | -72.9% | +2.7% | -77.9% | +113.9% | -73.0% | +199.6% |
| alltime | all time | -72.9% | +811.6% | -77.9% | +113.9% | -73.0% | +199.6% |
Enzo Biochem Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | $31.91 M(+2.7%) | $7.53 M(-6.2%) | $31.91 M(-4.3%) |
| Apr 2024 | - | $8.02 M(-6.2%) | $33.34 M(+1.6%) |
| Jan 2024 | - | $8.55 M(+9.6%) | $32.80 M(+3.3%) |
| Oct 2023 | - | $7.81 M(-12.9%) | $31.76 M(+2.3%) |
| July 2023 | $31.06 M(-4.8%) | $8.96 M(+19.7%) | $31.06 M(-196.9%) |
| Apr 2023 | - | $7.49 M(-0.4%) | -$32.04 M(+140.8%) |
| Jan 2023 | - | $7.51 M(+5.8%) | -$13.30 M(-200.6%) |
| Oct 2022 | - | $7.10 M(-113.1%) | $13.23 M(-59.5%) |
| July 2022 | $32.64 M(-72.3%) | -$54.14 M(-306.5%) | $32.64 M(-70.8%) |
| Apr 2022 | - | $26.22 M(-23.0%) | $111.60 M(-5.6%) |
| Jan 2022 | - | $34.05 M(+28.4%) | $118.17 M(+2.2%) |
| Oct 2021 | - | $26.52 M(+6.9%) | $115.59 M(-1.8%) |
| July 2021 | $117.73 M(+54.9%) | $24.81 M(-24.3%) | $117.73 M(+4.7%) |
| Apr 2021 | - | $32.80 M(+4.2%) | $112.44 M(+16.5%) |
| Jan 2021 | - | $31.47 M(+9.8%) | $96.55 M(+14.3%) |
| Oct 2020 | - | $28.66 M(+46.7%) | $84.47 M(+11.1%) |
| July 2020 | $76.02 M(-6.3%) | $19.53 M(+15.5%) | $76.02 M(-1.8%) |
| Apr 2020 | - | $16.90 M(-12.8%) | $77.42 M(-3.4%) |
| Jan 2020 | - | $19.38 M(-4.1%) | $80.17 M(+0.1%) |
| Oct 2019 | - | $20.21 M(-3.4%) | $80.12 M(-1.3%) |
| July 2019 | $81.17 M(-19.6%) | $20.92 M(+6.4%) | $81.17 M(-2.2%) |
| Apr 2019 | - | $19.66 M(+1.7%) | $83.00 M(-6.3%) |
| Jan 2019 | - | $19.33 M(-9.1%) | $88.57 M(-7.2%) |
| Oct 2018 | - | $21.26 M(-6.6%) | $95.40 M(-5.6%) |
| July 2018 | $101.01 M(-3.9%) | $22.75 M(-9.8%) | $101.01 M(-2.6%) |
| Apr 2018 | - | $25.23 M(-3.5%) | $103.71 M(-1.8%) |
| Jan 2018 | - | $26.15 M(-2.7%) | $105.57 M(-0.1%) |
| Oct 2017 | - | $26.88 M(+5.6%) | $105.68 M(+0.6%) |
| July 2017 | $105.09 M(+2.3%) | $25.45 M(-6.0%) | $105.09 M(-1.1%) |
| Apr 2017 | - | $27.09 M(+3.2%) | $106.24 M(+0.6%) |
| Jan 2017 | - | $26.26 M(-0.1%) | $105.58 M(+1.6%) |
| Oct 2016 | - | $26.28 M(-1.2%) | $103.88 M(+1.1%) |
| July 2016 | $102.77 M(+5.3%) | $26.60 M(+0.6%) | $102.77 M(+0.9%) |
| Apr 2016 | - | $26.43 M(+7.6%) | $101.87 M(+2.5%) |
| Jan 2016 | - | $24.56 M(-2.5%) | $99.42 M(+1.5%) |
| Oct 2015 | - | $25.18 M(-2.0%) | $97.95 M(+0.4%) |
| July 2015 | $97.60 M(+1.7%) | $25.70 M(+7.1%) | $97.60 M(+0.8%) |
| Apr 2015 | - | $23.99 M(+3.9%) | $96.81 M(+0.0%) |
| Jan 2015 | - | $23.09 M(-7.0%) | $96.80 M(+0.2%) |
| Oct 2014 | - | $24.82 M(-0.3%) | $96.64 M(+0.7%) |
| July 2014 | $95.95 M(+2.4%) | $24.91 M(+3.9%) | $95.95 M(+1.7%) |
| Apr 2014 | - | $23.98 M(+4.6%) | $94.31 M(+1.5%) |
| Jan 2014 | - | $22.93 M(-5.0%) | $92.93 M(+0.8%) |
| Oct 2013 | - | $24.13 M(+3.7%) | $92.21 M(-1.6%) |
| July 2013 | $93.71 M(-9.1%) | $23.27 M(+3.0%) | $93.71 M(-3.2%) |
| Apr 2013 | - | $22.60 M(+1.7%) | $96.85 M(-3.3%) |
| Jan 2013 | - | $22.21 M(-13.3%) | $100.20 M(-2.7%) |
| Oct 2012 | - | $25.63 M(-3.0%) | $102.96 M(-0.1%) |
| July 2012 | $103.08 M(+1.0%) | $26.41 M(+1.8%) | $103.08 M(-0.4%) |
| Apr 2012 | - | $25.95 M(+3.9%) | $103.49 M(+0.1%) |
| Jan 2012 | - | $24.97 M(-3.0%) | $103.37 M(+1.2%) |
| Oct 2011 | - | $25.75 M(-4.0%) | $102.13 M(+0.1%) |
| July 2011 | $102.03 M(+5.1%) | $26.82 M(+3.8%) | $102.03 M(+1.9%) |
| Apr 2011 | - | $25.83 M(+8.8%) | $100.16 M(+2.1%) |
| Jan 2011 | - | $23.73 M(-7.5%) | $98.12 M(+0.6%) |
| Oct 2010 | - | $25.65 M(+2.8%) | $97.57 M(+0.5%) |
| July 2010 | $97.08 M(+8.4%) | $24.95 M(+4.9%) | $97.08 M(+0.4%) |
| Apr 2010 | - | $23.79 M(+2.6%) | $96.67 M(+0.8%) |
| Jan 2010 | - | $23.19 M(-7.9%) | $95.94 M(+2.4%) |
| Oct 2009 | - | $25.16 M(+2.6%) | $93.67 M(+4.6%) |
| July 2009 | $89.57 M(+15.1%) | $24.53 M(+6.4%) | $89.57 M(+3.9%) |
| Apr 2009 | - | $23.06 M(+10.3%) | $86.22 M(+5.0%) |
| Jan 2009 | - | $20.92 M(-0.7%) | $82.11 M(+3.4%) |
| Oct 2008 | - | $21.06 M(-0.5%) | $79.42 M(+2.1%) |
| July 2008 | $77.80 M(+47.0%) | $21.18 M(+11.8%) | $77.80 M(+4.4%) |
| Apr 2008 | - | $18.95 M(+4.0%) | $74.53 M(+7.2%) |
| Jan 2008 | - | $18.23 M(-6.3%) | $69.54 M(+12.3%) |
| Oct 2007 | - | $19.45 M(+8.6%) | $61.91 M(+17.0%) |
| July 2007 | $52.91 M(+32.8%) | $17.91 M(+28.3%) | $52.91 M(+17.8%) |
| Apr 2007 | - | $13.96 M(+31.8%) | $44.91 M(+10.7%) |
| Jan 2007 | - | $10.59 M(+1.5%) | $40.58 M(+1.2%) |
| Oct 2006 | - | $10.44 M(+5.3%) | $40.10 M(+0.7%) |
| July 2006 | $39.83 M(-8.2%) | $9.92 M(+3.0%) | $39.83 M(-2.3%) |
| Apr 2006 | - | $9.63 M(-4.8%) | $40.78 M(-3.3%) |
| Jan 2006 | - | $10.12 M(-0.5%) | $42.15 M(-2.6%) |
| Oct 2005 | - | $10.16 M(-6.5%) | $43.27 M(-0.3%) |
| July 2005 | $43.40 M(+4.2%) | $10.87 M(-1.2%) | $43.40 M(+5.6%) |
| Apr 2005 | - | $11.00 M(-2.1%) | $41.12 M(-1.8%) |
| Jan 2005 | - | $11.23 M(+9.1%) | $41.88 M(+0.5%) |
| Oct 2004 | - | $10.30 M(+20.1%) | $41.67 M(+0.1%) |
| July 2004 | $41.64 M | $8.58 M(-27.1%) | $41.65 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2004 | - | $11.77 M(+6.7%) | $43.73 M(+0.3%) |
| Jan 2004 | - | $11.03 M(+7.3%) | $43.60 M(-4.6%) |
| Oct 2003 | - | $10.27 M(-3.6%) | $45.68 M(-13.4%) |
| July 2003 | $52.77 M(-2.3%) | $10.66 M(-8.4%) | $52.77 M(-5.6%) |
| Apr 2003 | - | $11.64 M(-11.2%) | $55.89 M(-5.7%) |
| Jan 2003 | - | $13.11 M(-24.5%) | $59.27 M(+2.2%) |
| Oct 2002 | - | $17.36 M(+25.9%) | $57.99 M(+7.3%) |
| July 2002 | $54.02 M(-7.5%) | $13.78 M(-8.3%) | $54.02 M(-10.1%) |
| Apr 2002 | - | $15.02 M(+27.0%) | $60.07 M(+1.8%) |
| Jan 2002 | - | $11.83 M(-11.6%) | $58.99 M(-3.4%) |
| Oct 2001 | - | $13.39 M(-32.5%) | $61.04 M(-0.8%) |
| July 2001 | $58.41 M(+16.7%) | $19.84 M(+42.4%) | $61.51 M(+10.0%) |
| Apr 2001 | - | $13.94 M(+0.4%) | $55.95 M(+2.5%) |
| Jan 2001 | - | $13.88 M(+0.1%) | $54.59 M(+4.4%) |
| Oct 2000 | - | $13.86 M(-2.9%) | $52.31 M(+4.5%) |
| July 2000 | $50.03 M(+12.9%) | $14.27 M(+13.5%) | $50.05 M(+8.0%) |
| Apr 2000 | - | $12.58 M(+8.4%) | $46.36 M(+0.8%) |
| Jan 2000 | - | $11.60 M(0.0%) | $45.98 M(+1.3%) |
| Oct 1999 | - | $11.60 M(+9.6%) | $45.38 M(+2.5%) |
| July 1999 | $44.30 M(+9.7%) | $10.58 M(-13.2%) | $44.27 M(+1.1%) |
| Apr 1999 | - | $12.19 M(+10.8%) | $43.79 M(+3.5%) |
| Jan 1999 | - | $11.00 M(+4.8%) | $42.30 M(+1.7%) |
| Oct 1998 | - | $10.50 M(+4.0%) | $41.60 M(+3.0%) |
| July 1998 | $40.40 M(+15.8%) | $10.10 M(-5.6%) | $40.40 M(-0.5%) |
| Apr 1998 | - | $10.70 M(+3.9%) | $40.60 M(+4.6%) |
| Jan 1998 | - | $10.30 M(+10.8%) | $38.80 M(+7.2%) |
| Oct 1997 | - | $9.30 M(-9.7%) | $36.20 M(+3.7%) |
| July 1997 | $34.90 M(+1.2%) | $10.30 M(+15.7%) | $34.90 M(+2.6%) |
| Apr 1997 | - | $8.90 M(+15.6%) | $34.00 M(+0.9%) |
| Jan 1997 | - | $7.70 M(-3.8%) | $33.70 M(-0.9%) |
| Oct 1996 | - | $8.00 M(-14.9%) | $34.00 M(-1.7%) |
| July 1996 | $34.50 M(+8.8%) | $9.40 M(+9.3%) | $34.60 M(+3.0%) |
| Apr 1996 | - | $8.60 M(+7.5%) | $33.60 M(+1.2%) |
| Jan 1996 | - | $8.00 M(-7.0%) | $33.20 M(+3.1%) |
| Oct 1995 | - | $8.60 M(+2.4%) | $32.20 M(+1.9%) |
| July 1995 | $31.70 M(+39.0%) | $8.40 M(+2.4%) | $31.60 M(+0.3%) |
| Apr 1995 | - | $8.20 M(+17.1%) | $31.50 M(+11.7%) |
| Jan 1995 | - | $7.00 M(-12.5%) | $28.20 M(+9.7%) |
| Oct 1994 | - | $8.00 M(-3.6%) | $25.70 M(+12.2%) |
| July 1994 | $22.80 M(+14.0%) | $8.30 M(+69.4%) | $22.90 M(+18.7%) |
| Apr 1994 | - | $4.90 M(+8.9%) | $19.30 M(+0.5%) |
| Jan 1994 | - | $4.50 M(-13.5%) | $19.20 M(-2.5%) |
| Oct 1993 | - | $5.20 M(+10.6%) | $19.70 M(-1.5%) |
| July 1993 | $20.00 M(-2.4%) | $4.70 M(-2.1%) | $20.00 M(-0.5%) |
| Apr 1993 | - | $4.80 M(-4.0%) | $20.10 M(-2.9%) |
| Jan 1993 | - | $5.00 M(-9.1%) | $20.70 M(0.0%) |
| Oct 1992 | - | $5.50 M(+14.6%) | $20.70 M(+1.5%) |
| July 1992 | $20.50 M(+3.5%) | $4.80 M(-11.1%) | $20.40 M(-2.4%) |
| Apr 1992 | - | $5.40 M(+8.0%) | $20.90 M(+2.5%) |
| Jan 1992 | - | $5.00 M(-3.8%) | $20.40 M(+2.0%) |
| Oct 1991 | - | $5.20 M(-1.9%) | $20.00 M(+0.5%) |
| July 1991 | $19.80 M(+2.1%) | $5.30 M(+8.2%) | $19.90 M(+1.5%) |
| Apr 1991 | - | $4.90 M(+6.5%) | $19.60 M(+0.5%) |
| Jan 1991 | - | $4.60 M(-9.8%) | $19.50 M(-0.5%) |
| Oct 1990 | - | $5.10 M(+2.0%) | $19.60 M(+1.0%) |
| July 1990 | $19.40 M(+60.3%) | $5.00 M(+4.2%) | $19.40 M(-1.5%) |
| Apr 1990 | - | $4.80 M(+2.1%) | $19.70 M(+13.9%) |
| Jan 1990 | - | $4.70 M(-4.1%) | $17.30 M(+16.9%) |
| Oct 1989 | - | $4.90 M(-7.5%) | $14.80 M(+22.3%) |
| July 1989 | $12.10 M(+33.0%) | $5.30 M(+120.8%) | $12.10 M(+31.5%) |
| Apr 1989 | - | $2.40 M(+9.1%) | $9.20 M(0.0%) |
| Jan 1989 | - | $2.20 M(0.0%) | $9.20 M(0.0%) |
| Oct 1988 | - | $2.20 M(-8.3%) | $9.20 M(+1.1%) |
| July 1988 | $9.10 M(+4.6%) | $2.40 M(0.0%) | $9.10 M(+2.2%) |
| Apr 1988 | - | $2.40 M(+9.1%) | $8.90 M(+2.3%) |
| Jan 1988 | - | $2.20 M(+4.8%) | $8.70 M(0.0%) |
| Oct 1987 | - | $2.10 M(-4.5%) | $8.70 M(0.0%) |
| July 1987 | $8.70 M(+19.2%) | $2.20 M(0.0%) | $8.70 M(-7.4%) |
| Apr 1987 | - | $2.20 M(0.0%) | $9.40 M(+2.2%) |
| Jan 1987 | - | $2.20 M(+4.8%) | $9.20 M(+17.9%) |
| Oct 1986 | - | $2.10 M(-27.6%) | $7.80 M(+6.8%) |
| July 1986 | $7.30 M(+40.4%) | $2.90 M(+45.0%) | $7.30 M(+46.0%) |
| Apr 1986 | - | $2.00 M(+150.0%) | $5.00 M(+2.0%) |
| Jan 1986 | - | $800.00 K(-50.0%) | $4.90 M(-12.5%) |
| Oct 1985 | - | $1.60 M(+166.7%) | $5.60 M(+7.7%) |
| July 1985 | $5.20 M(+48.6%) | $600.00 K(-68.4%) | $5.20 M(-5.5%) |
| Apr 1985 | - | $1.90 M(+26.7%) | $5.50 M(+25.0%) |
| Jan 1985 | - | $1.50 M(+25.0%) | $4.40 M(+15.8%) |
| Oct 1984 | - | $1.20 M(+33.3%) | $3.80 M(+46.2%) |
| July 1984 | $3.50 M | $900.00 K(+12.5%) | $2.60 M(+52.9%) |
| Apr 1984 | - | $800.00 K(-11.1%) | $1.70 M(+88.9%) |
| Jan 1984 | - | $900.00 K | $900.00 K |
FAQ
- What is Enzo Biochem annual revenue?
- What is the all time high annual revenue for Enzo Biochem?
- What is Enzo Biochem annual revenue year-on-year change?
- What is Enzo Biochem quarterly revenue?
- What is the all time high quarterly revenue for Enzo Biochem?
- What is Enzo Biochem quarterly revenue year-on-year change?
- What is Enzo Biochem TTM revenue?
- What is the all time high TTM revenue for Enzo Biochem?
- What is Enzo Biochem TTM revenue year-on-year change?
What is Enzo Biochem annual revenue?
The current annual revenue of ENZ is $31.91 M
What is the all time high annual revenue for Enzo Biochem?
Enzo Biochem all-time high annual revenue is $117.73 M
What is Enzo Biochem annual revenue year-on-year change?
Over the past year, ENZ annual revenue has changed by +$846.00 K (+2.72%)
What is Enzo Biochem quarterly revenue?
The current quarterly revenue of ENZ is $7.53 M
What is the all time high quarterly revenue for Enzo Biochem?
Enzo Biochem all-time high quarterly revenue is $34.05 M
What is Enzo Biochem quarterly revenue year-on-year change?
Over the past year, ENZ quarterly revenue has changed by -$280.00 K (-3.59%)
What is Enzo Biochem TTM revenue?
The current TTM revenue of ENZ is $31.91 M
What is the all time high TTM revenue for Enzo Biochem?
Enzo Biochem all-time high TTM revenue is $118.17 M
What is Enzo Biochem TTM revenue year-on-year change?
Over the past year, ENZ TTM revenue has changed by +$143.00 K (+0.45%)